Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Pharmacovigilance

10.11.2026

The FDA orders GLP-1 eye risk warnings for diabetes and weight-loss medicines after reviewing NAION evidence. Read what the changes mean for care.

23.07.2026

Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.

Search the archive

Browse by month